Quantcast
Last updated on April 19, 2014 at 7:22 EDT

Latest Exosome Stories

2013-04-08 12:28:37

NEW YORK, April 8, 2013 /PRNewswire/ -- Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostics for use in personalized medicine, today announced that the company is presenting a late-breaking abstract at the AACR Annual Meeting 2013, in Washington D.C. The abstract is titled "Exosome profiling of mRNAs and miRNAs in serum samples from GBM (glioblastoma multiforme) patients." It will be presented during Poster Session 47 from 1 to 5 p.m. EDT on April 8 by Johan Skog,...

2013-04-08 12:25:06

Exosomes and Microvesicles, the Official Journal of the American Society for Exosomes and Microvesicles, to Provide Scientific Community New Access to Ground-Breaking Research RIJEKA, Croatia, April 8, 2013 /PRNewswire/ -- InTech Open Access publisher is pleased to announce the collaboration with the American Society for Exosomes and Microvesicles (ASEMV) to publish the scientific journal Exosomes and Microvesicles, a peer-reviewed publication designed to bring together exosomes...

2013-04-01 23:01:45

In a first-of-its-kind experiment using microvesicles generated from mesenchymal bone marrow cells (MSCs) to treat cancer, neurological researchers at Henry Ford Hospital have discovered a novel approach for treatment of tumors. Specifically, the research team found that introducing genetic material produced by MSCs significantly reduced a particularly resistant form of malignant brain tumor in living lab rats. Detroit, Michigan (PRWEB) April 01, 2013 DETROIT — In a first-of-its-kind...

2013-03-07 23:01:59

New England Peptide acquires next generation exosome and microvesicle affinity technology for potential detection of cancer and other diseases. Gardner, MA (PRWEB) March 07, 2013 New England Peptide, Inc. (NEP) today announced that it has entered into a licensing agreement with the Atlantic Cancer Research Institute (ACRI). Under the terms of the agreement NEP has acquired the worldwide exclusive rights for Vn96 and a portfolio of other peptide compounds to be used for the research grade...

2013-02-28 08:31:39

SAN DIEGO, Feb. 28, 2013 /PRNewswire/ --Aethlon Medical, Inc. (OTCQB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce. I recently attended a healthcare related event that featured a panel discussion comprised of life science bankers and venture capitalists. While members of this panel often had differing viewpoints, they did mutually agree they were interested in emerging therapeutic candidates that provided more than one "shot on goal," meaning the...

2013-02-11 08:25:08

NEW YORK, Feb. 11, 2013 /PRNewswire/ -- Aethlon Medical, Inc. (OTC: AEMD), announced today that their February 7th RetailInvestorConferences.com presentation is now available for on-demand viewing. LINK: www.retailinvestorconferences.com> red "register/ watch event now" button Aethlon Medical's presentation will be available 24/7 for 90 days. Investors may download shareholder materials from the "virtual trade booth" for the next three weeks. About Aethlon Medical Aethlon Medical...

2013-02-06 08:26:33

NEW YORK, Feb. 6, 2013 /PRNewswire/ -- Aethlon Medical, Inc. (OTC: AEMD), announced today that Chairman and Chief Executive officer, James Joyce will present at RetailInvestorConferences.com. DATE: February 7, 2013 TIME: 2:00PM EST LINK: www.retailinvestorconferences.com> red "register/ watch event now" button This will be a live, interactive online event where investors are invited to ask the company questions in real-time- both in the presentation hall as well as the...

2013-02-05 08:35:10

SAN DIEGO, Feb. 5, 2013 /PRNewswire/ -- Aethlon Medical, Inc. (OTCQB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce. In our quest to innovate life-saving therapeutics, we have persevered through untold challenges to create a single medical device that offers to optimize the benefit of cancer and infectious disease therapies. As our endeavors transitioned beyond R&D, we thought we were cognizant of the entire alphabet soup of healthcare...

2013-01-29 08:27:08

SAN DIEGO, Jan. 29, 2013 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), today disclosed that a recent interview our Chairman and CEO, Jim Joyce participated in with the UT San Diego radio network is now available on-line. Mr. Joyce was interviewed on the Brian Britt Show which is broadcast on the UT San Diego radio network. The interview is available at http://bit.ly/UTSanDiego-BrianBrittShow-JimJoyce-Aethlon. Part one of the interview is on podcast number 03 and the second...

2013-01-23 08:29:21

SAN DIEGO, Jan. 23, 2013 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), announced that President, Rod Kenley will present today at the 15(th) International Conference on Dialysis being hosted by the Renal Research Institute. Mr. Kenley's presentation is entitled: "Extracorporeal Methods to Reduce Inflammation in Acute Sepsis," and is scheduled to begin at 10:25 a.m. Eastern Standard Time. The conference is being held at the Wyndham Rio Mar, Rio Grande, Puerto Rico. Additional details...